Abstract
Purpose
To examine the association of uveitis with hepatitis B (HBV) and hepatitis C (HCV) chronic infections
Method
This is a population-based cross-sectional study. The study encompassed 13,183 consecutive patients with uveitis and 65,331control subjects. The prevalence of chronic HBV and HCV infections was compared between patients diagnosed with uveitis and age-, sex-, and ethnicity-matched controls. Lifetime prevalence rates of HBV and HCV were calculated for patients with uveitis and control individuals. Odds ratio (OR) for HBV and HCV was evaluated across different strata.
Results
The lifetime prevalence rate of chronic HBV infection was greater in patients with uveitis than in controls (1.2% vs. 0.8%, respectively; P < 0.001). The association of HBV with uveitis was statistically significant among individuals older than 40 years of age, both sexes, and individuals of Jewish ethnicity. The lifetime prevalence of HCV was comparable between patients with uveitis and controls (0.8% vs. 0.7%, respectively; P = 0.189). Thus, no independently significant association was found between uveitis and HCV (fully-adjusted OR, 1.15; 95% CI, 0.93–1.42; P = 0.211).
Conclusions
Uveitis is associated with HBV. The association was more prominent among older and Jewish patients. Patients with uveitis may benefit from screening for HBV. An association between uveitis and HCV has not been found.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Data availability
Due to the nature of this research, the data cannot be shared publicly, so supporting data is not available.
References
Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16. https://doi.org/10.1016/j.ajo.2005.03.057.
Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr, Brézin AP, Chee SP, et al. Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative. Ophthalmology. 2018;125:757–73. https://doi.org/10.1016/j.ophtha.2017.11.017.
Jabs DA, Busingye J. Approach to the diagnosis of the uveitides. Am J Ophthalmol. 2013;156:228–36. https://doi.org/10.1016/j.ajo.2013.03.027.
Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16. https://doi.org/10.1016/j.ajo.2005.03.057.
Jabs DA. Immunosuppression for the Uveitides. Ophthalmology. 2018;125:193–202. https://doi.org/10.1016/j.ophtha.2017.08.007.
Hepatitis NIH: National Institute of Allergy and Infectious Diseases. https://www.niaid.nih.gov/diseases-conditions/hepatitis. Accessed April 10, 2021.
Lontchi-Yimagou E, Feutseu C, Kenmoe S, Djomkam Zune AL, Kinyuy Ekali SF, Nguewa JL, et al. Non-autoimmune diabetes mellitus and the risk of virus infections: a systematic review and meta-analysis of case-control and cohort studies. Sci Rep. 2021;11:8968 https://doi.org/10.1038/s41598-021-88598-6.
Ujiie I, Ujiie H, Yoshimoto N, Iwata H, Shimizu H. Prevalence of infectious diseases in patients with autoimmune blistering diseases. J Dermatol. 2020;47:378–84. https://doi.org/10.1111/1346-8138.15244.
Generali E, De Santis M, Isailovic N, Palermo B, Guidelli GM, Ceribelli A, et al. Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritis. Clin Exp Rheumatol. 2021;39:38–43. http://www.ncbi.nlm.nih.gov/pubmed/33337995 Accessed June 13, 2021
Troumani Y, Touhami S, Jackson TL, Ventura CV, Stanescu-Segall DM, Errera MH, et al. Association of anterior uveitis with acute Zika virus infection in adults. JAMA Ophthalmol. 2021;139:95–102. https://doi.org/10.1001/jamaophthalmol.2020.5131.
Forrester JV, Kuffova L, Dick AD. Autoimmunity, autoinflammation, and infection in uveitis. Am J Ophthalmol. 2018;189:77–85. https://doi.org/10.1016/j.ajo.2018.02.019.
Rocha VFD, de Oliveira AHP, Bandeira AC, Sardi SI, Garcia RF, Magalhães SA, et al. Chikungunya virus infection associated with encephalitis and anterior uveitis. Ocul Immunol Inflamm. 2018;26:677–9. https://doi.org/10.1080/09273948.2017.1358378.
Lim LL, Scarborough JD, Thorne JE, Graham E, Kempen JH, Mackensen F, et al. Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol. 2009;147:332–.e1. https://doi.org/10.1016/j.ajo.2008.08.019.
Efe C, Ozaslan E, Purnak T, Ozbalkan Z, Altiparmak E. Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol. 2010;149:684–5. https://doi.org/10.1016/j.ajo.2009.12.016. author reply 685
Yan KKL, Dinihan I, Freiman J, Zekry A. Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for Hepatitis C. Intern Med J. 2008;38:207–10. https://doi.org/10.1111/j.1445-5994.2007.01625.x.
Padidam S, Burke MT, Apple DB, Hu JK, Lin X. Association of Ledipasvir-Sofosbuvir treatment with uveitis in patients treated for Hepatitis C. JAMA Ophthalmol. 2019;137:568–70. https://doi.org/10.1001/jamaophthalmol.2019.0374.
Fried M, Conen D, Conzelmann M, Steinemann E. Uveitis after hepatitis B vaccination. Lancet. 1987;2:631–2. https://doi.org/10.1016/s0140-6736(87)93027-3.
Fraunfelder FW, Suhler EB, Fraunfelder FT. Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports. Cutan Ocul Toxicol. 2010;29:26–29. https://doi.org/10.3109/15569520903427717.
Tien P-T, Lin C-J, Tsai Y-Y, Chen HS, Hwang DK, Muo CH, et al. Relationship between uveitis, different types of viral hepatitis, and liver cirrhosis: a 12-year nationwide population-based cohort study. Retina. 2016;36:2391–8. https://doi.org/10.1097/IAE.0000000000001103.
Dick AD. Immune mechanisms of uveitis: insights into disease pathogenesis and treatment. Int Ophthalmol Clin. 2000;40:1–18. https://doi.org/10.1097/00004397-200004000-00003.
Dustin LB. Innate and adaptive immune responses in chronic HCV infection. Curr Drug Targets. 2017;18:826–43. https://doi.org/10.2174/1389450116666150825110532.
Mehta P, Reddivari AKR Hepatitis. StatPearls Publishing; 2021. http://www.ncbi.nlm.nih.gov/pubmed/32119436. Accessed April 12, 2021.
Lièvre M, Members of Epidemiology Working Group of French Pharmacovigilance Commission C, Costagliola D, Members of Epidemiology Working Group of French Pharmacovigilance C, Costagliola D, Evans S, Fourrier A, et al. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology. 2009;73:1426–7. https://doi.org/10.1212/WNL.0b013e3181bd1f7e.
Chevaux J-B, Nani A, Oussalah A, Venard V, Bensenane M, Belle A, et al. Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France. Inflamm Bowel Dis. 2010;16:916–24. https://doi.org/10.1002/ibd.21147.
Nard FD, Todoerti M, Grosso V, Monti S, Breda S, Rossi S, et al. Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs. World J Hepatol. 2015;7:344–61. https://doi.org/10.4254/wjh.v7.i3.344.
Koutsianas C, Thomas K, Vassilopoulos D. Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations. Ther Adv Musculoskelet Dis. 2020;12:1759720X20912646 https://doi.org/10.1177/1759720X20912646.
Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest. 2013;123:958–65. https://doi.org/10.1172/JCI64096.
Mehta P, Reddivari AKR Hepatitis. StatPearls Publishing; 2021. http://www.ncbi.nlm.nih.gov/pubmed/32119436. Accessed April 10, 2021.
de Smet MD, Taylor SR, Bodaghi B, Miserocchi E, Murray PI, Pleyer U, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011;30:452–70. https://doi.org/10.1016/j.preteyeres.2011.06.005.
Global Viral Hepatitis: Millions of People are Affected CDC. https://www.cdc.gov/hepatitis/global/index.htm. Accessed April 12, 2021.
Acknowledgements
ADC served as an advisor, investigator, or speaker for Abbvie, BI, Dexcel Pharma, Janssen, Novartis, Perrigo, Pfizer, and Rafa. None of the other authors have any conflicts of interest to declare. No funding was provided for this manuscript. The manuscript has not been published elsewhere, has not been evaluated for publication previously by another journal, and was not submitted simultaneously for publication elsewhere.
Author information
Authors and Affiliations
Contributions
MK- Conception or design of the work, Data analysis, and interpretation, Drafting the article, Final approval of the version to be published. OZ—Conception or design of the work, Data analysis, and interpretation, Drafting the article, Final approval of the version to be published. KK—Conception or design of the work, Data analysis, and interpretation, Drafting the article, Final approval of the version to be published. ADC—Conception or design of the work, Data collection, Critical revision of the article, Final approval of the version to be published. OM—Critical revision of the article, Final approval of the version to be published. OW- Conception or design of the work, Critical revision of the article, Final approval of the version to be published.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kridin, M., Zloto, O., Kridin, K. et al. The association of uveitis with hepatitis B and hepatitis C viruses: a large-scale population-based study. Eye 37, 720–724 (2023). https://doi.org/10.1038/s41433-022-02037-y
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-022-02037-y
This article is cited by
-
Ocular manifestations of liver disease: an important diagnostic aid
International Ophthalmology (2024)
